Bionano Genomics Statistics
Total Valuation
BNGO has a market cap or net worth of $14.13 million. The enterprise value is $10.92 million.
| Market Cap | 14.13M |
| Enterprise Value | 10.92M |
Important Dates
The last earnings date was Monday, August 10, 2026, after market close.
| Earnings Date | Aug 10, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BNGO has 11.78 million shares outstanding. The number of shares has increased by 314.06% in one year.
| Current Share Class | 11.78M |
| Shares Outstanding | 11.78M |
| Shares Change (YoY) | +314.06% |
| Shares Change (QoQ) | +5.16% |
| Owned by Insiders (%) | 0.06% |
| Owned by Institutions (%) | 10.17% |
| Float | 10.64M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.47 |
| Forward PS | 0.39 |
| PB Ratio | 0.45 |
| P/TBV Ratio | 0.47 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.36 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.48, with a Debt / Equity ratio of 0.21.
| Current Ratio | 2.48 |
| Quick Ratio | 1.42 |
| Debt / Equity | 0.21 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -114.16 |
Financial Efficiency
Return on equity (ROE) is -83.56% and return on invested capital (ROIC) is -38.97%.
| Return on Equity (ROE) | -83.56% |
| Return on Assets (ROA) | -32.56% |
| Return on Invested Capital (ROIC) | -38.97% |
| Return on Capital Employed (ROCE) | -85.73% |
| Weighted Average Cost of Capital (WACC) | 10.09% |
| Revenue Per Employee | $311,093 |
| Profits Per Employee | -$331,577 |
| Employee Count | 97 |
| Asset Turnover | 0.49 |
| Inventory Turnover | 2.29 |
Taxes
In the past 12 months, BNGO has paid $66,000 in taxes.
| Income Tax | 66,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -69.07% in the last 52 weeks. The beta is 1.64, so BNGO's price volatility has been higher than the market average.
| Beta (5Y) | 1.64 |
| 52-Week Price Change | -69.07% |
| 50-Day Moving Average | 1.16 |
| 200-Day Moving Average | 1.28 |
| Relative Strength Index (RSI) | 51.11 |
| Average Volume (20 Days) | 166,765 |
Short Selling Information
The latest short interest is 1.15 million, so 9.80% of the outstanding shares have been sold short.
| Short Interest | 1.15M |
| Short Previous Month | 1.07M |
| Short % of Shares Out | 9.80% |
| Short % of Float | 10.84% |
| Short Ratio (days to cover) | 10.41 |
Income Statement
In the last 12 months, BNGO had revenue of $30.18 million and -$32.16 million in losses. Loss per share was -$3.37.
| Revenue | 30.18M |
| Gross Profit | 14.34M |
| Operating Income | -32.19M |
| Pretax Income | -32.10M |
| Net Income | -32.16M |
| EBITDA | -22.87M |
| EBIT | -32.19M |
| Loss Per Share | -$3.37 |
Balance Sheet
The company has $9.92 million in cash and $6.70 million in debt, with a net cash position of $3.22 million or $0.27 per share.
| Cash & Cash Equivalents | 9.92M |
| Total Debt | 6.70M |
| Net Cash | 3.22M |
| Net Cash Per Share | $0.27 |
| Equity (Book Value) | 31.61M |
| Book Value Per Share | 2.68 |
| Working Capital | 14.84M |
Cash Flow
| Operating Cash Flow | -20.48M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 9.32M |
| Net Borrowing | -12.22M |
| Free Cash Flow | -20.48M |
| FCF Per Share | -$1.74 |
Margins
Gross margin is 47.50%, with operating and profit margins of -106.68% and -106.58%.
| Gross Margin | 47.50% |
| Operating Margin | -106.68% |
| Pretax Margin | -106.37% |
| Profit Margin | -106.58% |
| EBITDA Margin | -75.80% |
| EBIT Margin | -106.68% |
| FCF Margin | n/a |
Dividends & Yields
BNGO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -314.06% |
| Shareholder Yield | n/a |
| Earnings Yield | -227.58% |
| FCF Yield | -144.91% |
Analyst Forecast
The average price target for BNGO is $5.00, which is 316.67% higher than the current price. The consensus rating is "Buy".
| Price Target | $5.00 |
| Price Target Difference | 316.67% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | 24.33% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 27, 2025. It was a reverse split with a ratio of 1:60.
| Last Split Date | Jan 27, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:60 |
Scores
BNGO has an Altman Z-Score of -22.31 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -22.31 |
| Piotroski F-Score | 4 |